L
Legend Biotech Corporation
LEGN · NASDAQ · Healthcare · 3.8B
Price · close
$21.82
+2.63% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
4.0×
Enterprise value / EBITDAEV/EBITDA
-15.2×
Free cash flow yieldFCF yield
-4.2%
Return on equityROE
-29.6%
Operating margin
-13.3%
Net debt / EBITDAbalance-sheet strength
2.1×
Interest coverage
-6.4×
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.